ETF Managers Group’s Aimmune Therapeutics AIMT Stock Holding History

ETF Managers Group’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,431	Closed	-$187K	–	662
2020 Q3	$187K	Buy	+5,431	New	+$116K	0.01%	579

ETF Managers Group's AIMT Position: Q4 2020 in Review

ETF Managers Group sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 5,431 shares — an estimated $187K sold.

ETF Managers Group first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $187K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

ETF Managers Group reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
ETF Managers Group sold 5,431 Aimmune Therapeutics shares in Q4 2020, an estimated $187K.
ETF Managers Group first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
ETF Managers Group's Aimmune Therapeutics position peaked at $187K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on ETF Managers Group's 13F filing for Q4 2020, filed 16 Feb 2021.